Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1607, 2007-01, pp. : 5-5
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Pioglitazone the answer to managing type 2 DM in Europe?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 343, 2001-01 ,pp. :
Access to resources
Recommend
Raloxifene: a STAR performer in breast cancer prevention?
Inpharma, Vol. 1, Iss. 1546, 2006-01 ,pp. :
Pioglitazone improves measures of T2DM and dyslipidaemia
Inpharma, Vol. 1, Iss. 1607, 2007-01 ,pp. :
Pioglitazone the answer to managing type 2 diabetes in Europe?
Inpharma, Vol. 1, Iss. 1322, 2002-01 ,pp. :
Self-monitoring for T2DM in Canada: what do the models say?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 642, 2011-01 ,pp. :